Similar articles

• Belimumab Concentrations in Maternal Serum and Breast Milk During Breastfeeding and the Safety Assessment of the Infant: A Case Study.

  Saito J, Yakuwa N, Ishizuka T, Goto M, Yamatani A, Murashima A. Saito J, et al. Breastfeed Med. 2020 Jul;15(7):475-477. doi: 10.1089/bfm.2020.0068. Epub 2020 Apr 23. Breastfeed Med. 2020. PMID: 32326740 Free PMC article.
• Navigating monoclonal antibody use in breastfeeding women: Do no harm or do little good?

  LaHue SC, Gelfand AA, Bove RM. LaHue SC, et al. Neurology. 2019 Oct 8;93(15):668-672. doi: 10.1212/WNL.0000000000008213. Epub 2019 Sep 6. Neurology. 2019. PMID: 31492717 Review.
• Erenumab During Breastfeeding.

  Henze T. Henze T. Breastfeed Med. 2019 Sep;14(7):513-514. doi: 10.1089/bfm.2019.0162. Epub 2019 Aug 5. Breastfeed Med. 2019. PMID: 31381367 No abstract available.
• The use of biologic agents in pregnancy and breastfeeding.

  Horst S, Kane S. Horst S, et al. Gastroenterol Clin North Am. 2014 Sep;43(3):495-508. doi: 10.1016/j.gtc.2014.05.005. Epub 2014 Jul 5. Gastroenterol Clin North Am. 2014. PMID: 25110255 Review.
• Infliximab and adalimumab use during breastfeeding.

  Fritzsche J, Pilch A, Mury D, Schaefer C, Weber-Schoendorfer C. Fritzsche J, et al. J Clin Gastroenterol. 2012 Sep;46(8):718-9. doi: 10.1097/MCG.0b013e31825f2807. J Clin Gastroenterol. 2012. PMID: 22858514 No abstract available.